Lancet Neurol: Professor Xue Mengzhou, Zhengzhou University, reviewed the mechanisms of secondary injury and protection associated with inflammation after cerebral hemorrhage

Recently, Professor Xue Mengzhou, Director of cerebrovascular disease department of Zhengzhou University and director of the Key Laboratory of Cerebral Vascular Disease Translational Medicine in Henan Province, published a paper entitled: Neuroinflammation inintracerebral haemorrhage: immunotherapies with potential for translation in The Lancet Neurology(impact factor 30.039) in the field of neurology.
this is another effort by the Xue Meng Zhou team to publish microglia and macrophage phenotypes in in-intracerebral haemorrhage injury this year in Brain (impact factor 11.814).
despite decades of scientific research and advances in medical technology, the prognostics of patients with cerebral hemorrhage are still unsatisfactory and more effective interventions are urgently needed.
secondary brain injury mediated by inflammation cascading reactions in the brain after cerebral hemorrhage may be a key target for poor prognosmation and treatment.
The paper published by Professor Xue Meng Zhou's team provides a detailed and concise review of the mechanism of secondary injury and protection associated with inflammation after cerebral hemorrhage, summarizes and explains the most transformational potential immunotherapy drugs for cerebral hemorrhage, and provides valuable guidance and reference for the further development of basic and clinical research in this field.
may 2002, the Lancet Neurology journal ranked first in the journal Clinical Neurology.
the magazine's purpose of publishing authoritative, independent, and highest quality neurology research papers has been used as a benchmark by neurologists and neurologists around the world.
Xue Mengzhou, M.D., special allowance expert of the State Council, special professor of disciplines of Zhengzhou University, doctoral tutor, director of key disciplines of cerebrovascular disease in Henan Province, leader of special disciplines of neurology in Henan Province, leader of the innovative science and technology team of cerebrovascular disease translation medicine in Henan Province, director of cerebrovascular diseases at the Second Affiliated Hospital of Zhengzhou University.
published more than 70 SCI papers, the total impact factor of more than 360 points, the total number of references more than 3000 times, more than 160 conference papers.
Xue Meng Zhou has been committed to the study of cerebral hemorrhage, has reported in the international community self-blood injection of animal models of cerebral hemorrhage, has been recognized by the academic community and widely cited more than 900 times.